Heterogeneous nuclear ribonucleoprotein A1 pseudogene 19 (HNRNPA1P19)

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 19 (HNRNPA1P19) refers to a genomic sequence that resembles the gene encoding heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), but it is a pseudogene, meaning it does not produce a functional protein product, nor does it participate in known cellular or pathological processes directly. This pseudogene is catalogued in gene databases as a non-protein-coding entity and has no confirmed role as a druggable target, biomarker, or molecular participant in cellular signaling or disease biology. Distinct from its functional parent gene HNRNPA1 (which is involved in RNA metabolism, splicing, and stress granule formation and is implicated in neurological disorders and cancer[2][3][5][6][8][9]), HNRNPA1P19 lacks these properties and has no established significance in molecular pharmacology or therapeutic targeting[1][4][10]. Summary: HNRNPA1P19 is a pseudogene—essentially a non-functional copy of the HNRNPA1 gene—and is not considered a drug target, receptor, enzyme, transporter, or related therapeutic target. If your query was in the context of drug discovery or disease mechanism analysis, focus should be shifted to the parent gene HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1), which is functionally and clinically relevant[2][3][5][6][8][9].

Other names

HNRNPA1P19